Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Please provide your email address to receive an email when new articles are posted on . Before the pandemic, 34.5% of patients with disabilities and end-stage kidney disease transitioned to home ...

A new device for the percutaneous creation of an arteriovenous fistula (AVF) for hemodialysis access in patients with kidney disease has excellent cumulative patency rates out to 2 years and is ...

The University of Alabama at Birmingham (UAB) Kidney-Pancreas Transplant faculty have busy elective dialysis access practices. Almost 1,000 operative cases are performed each year. A strong emphasis ...

The Society of Interventional Radiology (SIR) published new practice guidance for the creation of percutaneous arteriovenous fistulas (pAVFs) for dialysis access. The guidance was published online in ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

For decades, the United States has grappled with the complexities of chronic kidney disease and the plight of the almost ...

Patients with kidney failure must often have hemodialysis one or more times each week to assist their kidneys in filtering waste products out of their blood streams. The dialysis filtering process ...

Access to dialysis care remains a life-or-death issue for the nearly 520,000 Americans currently on dialysis, according to National End Stage Renal Disease Census data. While the United States has ...

Japan: Early detection of vascular access (VA) stenosis remains essential for patients undergoing hemodialysis, as untreated narrowing can compromise dialysis efficiency and lead to access failure.

DURHAM, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...